138922-15-3

Upstream product

• 27687-13-4 trans-4-(N-carbobenzyloxy)aminomethyl-1-cyclohexane carbonyl chloride 
• 1137-42-4 4-Hydroxybenzophenone 
• 138849-03-3 H-Lys(Boc)-4-benzoylphenoxymethyl ketone hydrochloride 
• 138849-02-2 Z-Lys(Boc)-4-benzoylphenoxymethyl ketone 
• 138849-01-1 N_α-Cbz-N_ε-Boc-lysyl chloromethane 
• 27687-12-3 (1r,4r)-4-({[(benzyloxy)carbonyl]amino}methyl)cyclohexane-1-carboxylic acid 
• 138884-66-9 ((S)-7-(4-Benzoyl-phenoxy)-5-{[4-(benzyloxycarbonylamino-methyl)-cyclohexanecarbonyl]-amino}-6-oxo-heptyl)-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Development of active center-directed inhibitors against plasmin

Active center-directed inhibitors of plasmin were designed based on the structure of specific substrates of plasmin and then synthesized. Their effects on plasmin were examined and the structure-inhibitory activity relationship was studied. N(α)-trans-4-A